Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The firm also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
107
Frequently Asked Questions
What is Market Cap of Accelerate Diagnostics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Accelerate Diagnostics Inc market cap is $176,500.00.
What is the 52-week high for Accelerate Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Accelerate Diagnostics Inc 52 week high is $0.049 as of September 28, 2025.
What is the 52-week low for Accelerate Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Accelerate Diagnostics Inc 52 week low is $0.0038 as of September 28, 2025.
What is Accelerate Diagnostics Inc stock price today?
Accelerate Diagnostics Inc stock price today is $0.035.
What was Accelerate Diagnostics Inc stock price yesterday?
Accelerate Diagnostics Inc stock price yesterday was $0.088.
What is the PE ratio of Accelerate Diagnostics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Accelerate Diagnostics Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Accelerate Diagnostics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Accelerate Diagnostics Inc P/B ratio is -0.0031.
What is the 50-day moving average of Accelerate Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Accelerate Diagnostics Inc 50-day moving average is $0.0096.
How many employess does Accelerate Diagnostics Inc has?
